The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Sabate, O.
* Articles by Thibaut, F.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Sabate, O.
* Articles by Thibaut, F.

Am J Psychiatry 1994; 151:107-111
Copyright © 1994 by American Psychiatric Association


REGULAR ARTICLES

Failure to find evidence for linkage or association between the dopamine D3 receptor gene and schizophrenia

O Sabate, D Campion, T d'Amato, MP Martres, P Sokoloff, B Giros, M Leboyer, M Jay, F Guedj and F Thibaut
Laboratoire de genetique Moleculaire de la Neurotransmission et des Processus Neurodegeneratifs; CHS du Rouvray, Sotteville les Rouen, France.

OBJECTIVE: This study was performed to assess the possible involvement of the dopamine D3 receptor gene (DRD3) in the etiology of schizophrenia. The authors' approach included a population study and a family study using both parametric (lod score) and nonparametric (affected pedigree member) methods of linkage analysis. METHOD: Two different DNA markers were studied at the DRD3 locus. The family study included 35 multiplex families of schizophrenic subjects for the linkage analyses. The population study involved 50 unrelated schizophrenic subjects and 50 normal comparison subjects from the same ethnic and geographic origin. RESULTS: Whichever clinical classification was used to define the pathological phenotype (schizophrenia or schizophrenia spectrum), the results of the lod score and affected pedigree member studies did not provide any evidence of linkage of the DRD3 gene to the illness. The negative results of the association study reinforce these results. CONCLUSIONS: The hypothesis that the DRD3 gene has a predisposing role in schizophrenia was not supported by these population and family studies. However, the possibility that this gene has a role in the etiology of the disease cannot be definitely excluded because of the intrinsic limitations of the methods of analysis and the number of subjects studied.


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
B. Levant
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Pharmacol. Rev., September 1, 1997; 49(3): 231 - 252.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1994 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org